ArticlePharmacoEconomics2026
From Paper to Platform: Updating the Dutch Costing Manual and Launching a Web Application.
Article in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of a diagnostic strategy for appendicitis in children with acute abdominal pain in primary care: study protocol for a hybrid type 1 cluster randomised controlled trial.Diagnostic and prognostic research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveThe Dutch costing manual, part of the national guideline for economic evaluations, provides reference prices and standardized cost calculation methods to ensure transparency and comparability. Since its last update in 2015, new evidence, updated cost data, and user needs prompted an updated version to reflect current best practices and expand scope. The aim of this article is to present the update of the costing manual and the introduction of the web application facilitating regular updates.
methodsThe update of the costing manual followed a three-step approach. First, improvement needs were identified by user surveys and experts. Secondly, methodological guidance was revised using recent literature, national data sources, and expert input. Thirdly, the reference prices were updated. In parallel, a technical web application was developed and tested to facilitate ongoing digital access and regular updates.
resultsThe updated costing manual consists of revised and updated references prices, including expanded intersectoral reference prices (e.g., education and justice). Clearer methodological guidance and improved transparency were established. Testing showed that the web-based application was intuitive to use and accurately reproduced reference prices consistent with the updated costing manual.
conclusionsThe costing manual was updated in line with the recent guidelines for economic evaluations. The manual is a comprehensive manual for use in costing studies for economic evaluations in healthcare from a societal perspective. The web-based application translated the costing manual into a practical digital tool, automating cost calculations and demonstrated usability, accuracy, and consistency with the manual.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.